XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Preferred A Stock
Additional Paid-In Capital
Accumulated Deficit
Total Stockholders’ Equity attributable to Agrify
Non- Controlling Interests
Total
Balance at Dec. 31, 2020 $ 4 $ 19,827 $ (26,510) $ (6,679) $ 225 $ (6,454)
Balance (in Shares) at Dec. 31, 2020 4,211,677 100,000          
Stock-based compensation 2,135 2,135 2,135
Beneficial conversion feature associated with amended Convertible Promissory Notes 3,869 3,869 3,869
Conversion of Convertible Notes $ 2 13,098 13,100 13,100
Conversion of Convertible Notes (in Shares) 1,697,075          
Issuance of Common Stock – Initial Public Offering (“IPO”), net of fees $ 6 56,955 56,961 56,961
Issuance of Common Stock – Initial Public Offering (“IPO”), net of fees (in Shares) 6,210,000          
Issuance of Common Stock – Secondary public offering, net of fees $ 6 79,833 79,839   79,839
Issuance of Common Stock – Secondary public offering, net of fees (in Shares) 6,388,888          
Conversion of Preferred A Stock $ 1 (1)
Conversion of Preferred A Stock (in Shares) 1,373,038 (100,000)          
Exercise of options 439 439 439
Exercise of options (in Shares) 174,223          
Exercise of warrants 5 5 5
Exercise of warrants (in Shares) 240,233            
Net loss (3,810) (3,810) (33) (3,843)
Balance at Mar. 31, 2021 $ 19 176,160 (30,320) 145,859 192 146,051
Balance (in Shares) at Mar. 31, 2021 20,295,134          
Balance at Dec. 31, 2021 $ 21 196,013 (58,975) 137,059 365 137,424
Balance (in Shares) at Dec. 31, 2021 22,207,103            
Stock-based compensation 953 953 953
Issuance of Common Stock and warrants in private placement $ 2 25,795 25,797 25,797
Issuance of Common Stock and warrants in private placement (in Shares) 2,450,350            
Issuance of debt and warrants in private placement 13,230 13,230 13,230
Acquisition of Lab Society 1,903 1,903 1,903
Acquisition of Lab Society (in Shares) 297,929            
Exercise of options 10 10 10
Exercise of options (in Shares) 4,220            
Exercise of warrants $ 2 (1) 1 1
Exercise of warrants (in Shares) 1,583,288            
Net loss (8,882) (8,882) 1 (8,881)
Balance at Mar. 31, 2022 $ 25 $ 237,903 $ (67,857) $ 170,071 $ 366 $ 170,437
Balance (in Shares) at Mar. 31, 2022 26,542,890